YAP1 and gastric cancer: The reported YAP antagonists verteporfin and Vgll4-mimicking peptide, which elicit positive effects on tumour growth suppression in liver and gastric cancers, may cause anti-fibrotic effects in an incomplete repair I/R AKI model [30,40].